Sustained involvement across NanoREG II (regulatory grouping), NanoInformaTIX (modelling platform), and HARMLESS (risk assessment and NAMs)
UNIWERSYTET GDANSKI
Polish university strong in nanosafety science, mitochondrial DNA repair, and responsible research governance, with growing work in explainable AI and climate resilience.
Their core work
The University of Gdańsk is a major Polish research university with particular strength in molecular biology, nanosafety science, and responsible research governance. Their life sciences teams investigate fundamental mechanisms of DNA repair in mitochondria and viral metagenomics, while their materials science groups contribute to European nanomaterial safety frameworks — developing grouping approaches, predictive models, and safe-by-design strategies. In parallel, the university is an active player in institutional transformation for open science, gender equality, and citizen engagement in biosciences. Their marine biology infrastructure connects to the EMBRC network through the ASSEMBLE Plus project, reflecting Gdańsk's strategic position on the Baltic coast.
What they specialise in
ERC-funded MitoRepairosome on mitochondrial DNA repair, IMMUNE-GENEMEMO on transcriptional memory, and Virus-X on viral metagenomics
STARBIOS 2, RESBIOS, MINDtheGEPs, and reSEArch-EU all address gender equality, open science, ethics, and governance transformation
ASSEMBLE Plus provides transnational access to marine research stations and experimental facilities
SCORE focuses on climate resilience in coastal cities using digital twins; reSEArch-EU addresses sustainability and green campus transformation
KATY project applies explainable machine learning to clinical knowledge, their largest-funded participant role at EUR 650K
How they've shifted over time
In the early H2020 period (2015–2018), the University of Gdańsk focused heavily on nanosafety regulation and responsible research governance — keywords like safe-by-design, societal engagement, gender, ethics, and open access dominated their portfolio. From 2019 onward, a clear shift emerged toward fundamental life sciences (DNA repair, structural biology, transcriptional memory) alongside new engagement in digital tools (explainable AI), climate resilience, and social policy. The university has diversified from a governance-and-safety profile into a broader research institution with growing ambitions in molecular biology and data-driven health applications.
Gdańsk is building fundamental life science capacity (backed by ERC funding) while maintaining its nanosafety and governance expertise — expect them to seek projects combining molecular biology with responsible innovation frameworks.
How they like to work
The University of Gdańsk is predominantly a consortium partner (16 of 19 projects), joining large multi-country research networks rather than leading them. Their 3 coordinator roles are all in life sciences (AMBER, MitoRepairosome, IMMUNE-GENEMEMO), suggesting they lead where they have deep bench strength. With 265 unique partners across 37 countries, they are a well-connected node — not a hub that builds its own consortia, but a reliable, broadly networked contributor that different coordinators keep inviting back.
With 265 unique consortium partners across 37 countries, the University of Gdańsk has one of the broader collaboration networks among Polish universities in H2020. Their partnerships span Western Europe extensively, with strong connections to marine and bioscience institutions across the continent.
What sets them apart
Few universities combine deep nanosafety expertise with fundamental molecular biology research AND institutional governance reform — Gdańsk spans all three. Their ERC Starting Grant (MitoRepairosome, EUR 1.5M) signals internationally competitive life sciences, while their sustained nanosafety work across three project generations makes them one of Poland's go-to partners for materials risk assessment. For consortium builders, they offer a rare combination: hard science credibility plus genuine experience in responsible research integration and open science practices.
Highlights from their portfolio
- MitoRepairosomeERC Starting Grant worth EUR 1.5M — their largest single award and a mark of individual research excellence in mitochondrial DNA repair
- NanoInformaTIXCentral to building Europe's nanoinformatics modelling platform, connecting QSAR, PBPK models, and systems biology for nanomaterial safety
- KATYTheir largest participation funding (EUR 650K) and a pivot into explainable AI for clinical decision support — signals a new strategic direction